Precipio Inc (PRPO)

[awaitingamove]

Revenues are increasing and growing acceptance in the market place.

Snapshot of recent developement..also would expect someone to partner with PRPO at some point..the stock has shown signs of a breakout in the last few days and today it popped..

Precipio reported that on a preliminary basis, revenue for the second quarter is expected to be $815,000, up from $260,000 in the second quarter of 2017. This will represent a growth of 213%. In the fourth quarter of 2017, year over year growth was 199%. For the fourth quarter of 2018, the number was 187%. Precipio also said that revenue for the first half of 2018 is estimated at $1.5M. This is three times compared to the $0.5M in the first half of 2017. CEO Ilan Danieli remarked, "These results represent further validation of our high growth strategy to rapidly gain pathology services market share, and commercialize our unique liquid biopsy, mutation detection products for cancer. We are confident with the potential effect on market and enterprise value resulting from this trend, as we continue to hit revenue and commercialization milestones."